Navigation Links
Shire Divests Non-Core Product Portfolio to Almirall
Date:10/8/2007

Reinforcing Strategic Focus on Growth-Driving Global Products

BASINGSTOKE, England, October 8 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announces that it has agreed to sell a portfolio of non core products to Almirall for a cash consideration of $213m. The portfolio includes the dermatology products, SOLARAZE(R) (3% gel diclofenac sodium) and VANIQA(R) (eflornithine hydrochloride), and six other non-promoted products1 across a range of indications, which are principally sold by Shire in the UK, France, Germany, Italy, Spain and Ireland.

The divested products are no longer core to Shire's strategy of building market leading positions in specialty markets through the development and commercialization of competitive global products with strong intellectual property protection. Shire's focus is on building its attention deficit hyperactivity disorder (ADHD), human genetic therapies, gastrointestinal and renal diseases businesses and, with its recent in-licensing of JUVISTA(R) (human recombinant TGFβ3) from Renovo plc, Shire intends to build a new specialty area of regenerative medicine. Shire's specialty products are increasingly global in their reach - for example Shire aims to expand its ADHD expertise to markets outside the U.S. within the next two years, with an initial focus on the EU. This product divestment will enable Shire to pursue this strategy in a more concentrated way.

Shire plc Chief Executive, Matthew Emmens comments:

"Our strategic focus is clear and our emphasis in the international markets is on developing competitive positions for our global products that meet the needs of the specialist physicians and their patients, in our chosen areas of expertise. Almirall is well positioned to ensure future development and investment in the products we are divesting, which are no longer core to our strategy."

Almirall Chairman and CEO, Dr Jorg
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. A New C-Terminal GST Vector for Protein Production in S. pombe
2. Safe Production of High-Titer Retrovirus
3. Production of Full-Length, Biologically Active MEK1WT and MEK1CA
4. Yeast Protein Production System Features High Yields and One-Step Purification
5. Identification of Differentially Expressed Gene Products with the CastAway System*
6. High-Throughput System Generates Ultra-Pure PCR Products Suitable for All Applications
7. cMaster RTplusPCR System for increased sensitivity and product length in RT-PCR
8. Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray Ion Trap Mass Spectrometry
9. Advantages of Roche Applied Science amplification products
10. Find the optimal product for your PCR application
11. Product overview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... (PRWEB) October 30, 2014 Whitehouse Laboratories ... its ICH Stability Testing and Package Test Capacity. Responding ... centers on a dramatic increase in environmental chamber storage ... stability, storage and aging samples to be securely held ... this major capital expenditure has already taken place with ...
(Date:10/30/2014)... , Oct. 30, 2014 Isis Pharmaceuticals, Inc. ... today announced that management will present a company overview at ... 8:30 a.m. ET in Boston, MA. ... available on the "Investors & Media" section of the Company,s ... the Isis website within 48 hours and will be archived ...
(Date:10/30/2014)... solution to one of the key challenges in the ... of Sussex physicists. , In a paper published today ... Garraway and colleagues show how to make a new ... Quantum technology devices, such as high-precision sensors and specialised ... of atoms. But the methods for trapping these tiny ...
(Date:10/27/2014)... October 27, 2014 The new ... Type (High & Medium), Sub-type (Primary & Secondary), ... Infrastructure & Transportation & Power Generation) - Trends ... GIS market with analysis and forecasting of the ... Data Tables with 52 Figures spread through 146 ...
Breaking Biology Technology:Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 2Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4
... Accelerate Anesiva,s Penetration of the Hospital Market with ... ... FRANCISCO, Calif. and SCHAUMBURG, Ill., Oct. 11, Anesiva, Inc. (Nasdaq: ... Sagent will,co-promote for three years Anesiva,s Zingo(TM) (lidocaine hydrochloride,monohydrate) powder intradermal ...
... England, October 11 Oxford Genome Sciences (UK),Ltd ... its Scientific,Advisory Board (SAB) with the appointment of ... Immunogenetics Laboratory in the Weatherall,Institute of Molecular Medicine ... the fundamental genetic and biological changes which,lead to ...
... Oct. 11 Solstice Neurosciences, Inc.,("Solstice") announced the ... of,Directors. Mr. Smith will serve as Executive Chairman ... served as Chairman since Solstice,was founded in July ... industry experience,and expertise to Solstice that will be ...
Cached Biology Technology:Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals 2Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals 3Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals 4Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board 2Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board 3Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc. 2
(Date:10/29/2014)... industrial products are in the environment – and hundreds ... scientists have yet to determine whether they cause health ... that by estimating which substances people are exposed to ... ACS journal Environmental Science & Technology . , ... to human health of any given substance depend primarily ...
(Date:10/29/2014)... . Meiosis ... at the Max F. Perutz Laboratories (MFPL) of the ... dived into the process of meiosis in specific plant ... of the standard meiotic phases. The researchers describe the ... . , Meiosis is the two-step series of cell ...
(Date:10/29/2014)... the living world compete with members of their ... much they invest into their competitive ability. Some ... access to high-quality resources, while others seem to ... lower-quality resources that are left over for them. ... human societies seems to fluctuate considerably over time. ...
Breaking Biology News(10 mins):Meiotic cell division 'the other way round' 2Evolution of competitiveness 2Evolution of competitiveness 3
... have isolated a new peptide antibiotic from the ... many diseases in oysters. , The new antimicrobial ... bacteria in Crassostrea virginica, a species that is ... Atlantic and Gulf Coast fisheries. , "This peptide ...
... Mitragotri, a professor of chemical engineering at the University ... injections have led to active research and development of ... prefer to avoid injections, the stakes are enormously higher ... a needle. In third world countries, improper and unsafe ...
... formation follows a dynamic pattern, allowing for retrieval from different ... to remember, said a researcher at Baylor College of Medicine. ... molecular and cellular biology at BCM, theorizes, based on his ... trace in Drosophila or fruit flies is formed in a ...
Cached Biology News:Tracking the memory trace 2
See product name for description....
... 20 Amino Acid length max , MS-spec check ... customer for future usage conjugation of peptide to KLH protein , ... days/each , Pre-immune bleed x1 /each ... Test bleed (app. 5 ml) x1 /each , ...
... following: , Coated Capture Antibody: 12 x 8-well ... 300 mL of 2X concentrate , Beta ... peptide , Lyophilized Standard Diluent: 3 mL , ... Secondary Antibody-HRP: 30 microL of concentrate , OPD ...
Human Cell Line Slides...
Biology Products: